
A medication that helps one person a great deal may cause adverse effects, fail to work, or require a different dose in someone else. It is not always “bad luck” or a wrongly indicated treatment: part of the response may be written in DNA. A pharmacogenetic medication test studies genetic variants related to how the body processes and responds to certain drugs.
For anyone living with chronic treatment, unexpected reactions, or several medications, that information can change the quality of the conversation with their physician. Pharmacogenetics does not replace clinical assessment or enable self-medication. It provides data to ask more precise questions, anticipate known risks, and consider therapeutic alternatives with greater grounding.
Explore Ajolote Azul PGx testing.
Pharmacogenetics looks at genes involved in two distinct processes. The first is pharmacokinetics: how the body absorbs, transforms, and eliminates a drug. The second is pharmacodynamics: how the drug acts on its biological target and how likely it is to produce the expected effect.
Many tests review variants in enzyme families such as CYP2D6, CYP2C19, and CYP2C9. These hepatic enzymes metabolize numerous commonly used treatments. Depending on the genetic variant, a person may have reduced, typical, or increased metabolic activity. That can change drug concentration in blood and therefore the probability of lack of response or adverse effects.
Genes linked to hypersensitivity reactions, response to anticoagulants, certain psychiatric drugs, analgesics, cardiovascular treatments, and oncology therapies may also be analyzed. The exact panel matters: not all studies evaluate the same genes or cover the same therapeutic areas.
The result does not state that a medication “will work” or “will not work” in absolute terms. It expresses a clinical association: for a given variant and drug, evidence may exist to consider a different dose, closer monitoring, a preferred alternative, or avoiding use in specific circumstances.
A pharmacogenetic test is especially useful when there is a history of responses that are hard to explain. For example, if an analgesic does not control pain despite correct use, if an antidepressant causes intense side effects at low doses, or if a treatment seems to require repeated adjustments.
It can also add value in polypharmacy, especially older adults or patients with chronic conditions. Here genetics does not replace reviewing drug interactions, renal function, hepatic function, diet, and supplements. But it adds a layer of information that helps explain why two patients with the same prescription may not need the same management.
In oncology, cardiology, psychiatry, and pain management, utility depends on the specific treatment and available guidelines. Some scenarios have well-established pharmacogenetic recommendations; others still have limited evidence. The decision to perform the test should have a clear purpose: resolve a present clinical question or hold preventive information that may help before certain drugs are needed.
Receiving a report does not mean changing the dose on your own. Responsible interpretation integrates genetics, diagnosis, age, medical history, pregnancy, lab results, other treatments, and therapeutic goals.
Imagine two people with a variant that reduces metabolism of a drug. One might need an alternative from the start because they already had a serious adverse effect. The other might use it with monitoring and a clinical adjustment. The variant is the same; the context is not. That is the difference between having genetic data and turning it into a useful medical decision.
An interpretation consult is valuable because it translates terms like “intermediate metabolizer” or “increased risk” into practical questions: Does this result apply to my current prescription? Should I watch for certain symptoms? Which specialist should know? What information should I keep for future treatments?
At Ajolote Azul, the process is designed so analysis does not stay a technical document: the kit can be done with a buccal swab sample at home, followed by a digital report and specialist consult to contextualize findings. The goal is not to label a person by their genes but to use genetics to support informed decisions.
The most concrete benefit of pharmacogenetics is reducing trial and error when applicable evidence exists. It can help identify medications where extra caution is warranted, detect a possible explanation for an atypical response, and give the physician additional information before prescribing.
However, DNA does not explain everything. Medication response also changes with body weight, age, microbiome, diet, alcohol or tobacco use, treatment adherence, liver or kidney disease, and interactions with other drugs. A favorable result does not guarantee efficacy, and an alert result does not always mean the drug is forbidden.
Be wary of promises of a perfect prescription from a single test. Pharmacogenetics is a powerful clinical tool when used with medical evaluation—not a substitute for professional judgment. Its strength is making a variable that once stayed hidden more visible.
Before requesting the study, gather names and doses of medications you currently take—including over-the-counter drugs, vitamins, herbal products, and supplements. Also note treatments you stopped due to side effects, allergies, or lack of response. That history can make interpretation much more relevant.
When you receive the report, first review which genes and drugs were analyzed. Ask whether a recommendation is based on recognized clinical guidelines, whether it applies to your current treatment, and what action your physician suggests. If the report mentions a variant relevant for the future, store it securely and share it with health professionals when a new medication is prescribed.
Privacy deserves the same attention. Your genetic data are sensitive information. Before choosing a service, confirm how the sample is processed, where data are stored, who can access them, and what controls protect your information. The convenience of an at-home kit should come with clear lab and confidentiality standards.
Personalized medicine is not a promise that every decision will be simple. It is replacing part of uncertainty with relevant information. For some people a pharmacogenetic test will be decisive before starting a drug; for others it will support future prescriptions. In both cases its value appears when results translate into a concrete clinical conversation.
Knowing how your genetics may influence certain medications does not dictate your treatment, but it lets you participate with better questions. Bring your results to your visit, share them with the right specialist, and turn a DNA data point into a decision that better protects your long-term health.
See PGx price and report details or book a consult to discuss your medications with support. If nutrition is also on your list, compare NGx and Combo options.
Specialist in wellness, nutrition and holistic health. Passionate about sharing science-based knowledge to improve quality of life.
Discover more content on this topic that might interest you

Precision oncology analyzes the tumor and guides specific treatments with informed clinical decisions, expert follow-up, and individual context.

Why two people respond differently to the same diet—and how nutrigenetics helps you personalize nutrition, energy, and weight with clinical context.

How to choose the right DNA test in Mexico for nutrition, medications, or prevention—and why interpretation matters as much as the kit.
Pricing, covered medications, and how to book your consult.